BioLight Life (Israel) Performance
| BOLT Stock | ILS 530.00 4.00 0.76% |
On a scale of 0 to 100, BioLight Life holds a performance score of 7. The firm shows a Beta (market volatility) of 0.92, which signifies possible diversification benefits within a given portfolio. BioLight Life returns are very sensitive to returns on the market. As the market goes up or down, BioLight Life is expected to follow. Please check BioLight Life's total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether BioLight Life's price patterns will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in BioLight Life Sciences are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, BioLight Life sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 30 M | |
| Total Cashflows From Investing Activities | 13.5 M | |
| Free Cash Flow | -10.7 M |
BioLight |
BioLight Life Relative Risk vs. Return Landscape
If you would invest 44,000 in BioLight Life Sciences on September 2, 2024 and sell it today you would earn a total of 9,000 from holding BioLight Life Sciences or generate 20.45% return on investment over 90 days. BioLight Life Sciences is generating 0.5636% of daily returns and assumes 6.162% volatility on return distribution over the 90 days horizon. Simply put, 54% of stocks are less volatile than BioLight, and 89% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
BioLight Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioLight Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BioLight Life Sciences, and traders can use it to determine the average amount a BioLight Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0915
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BOLT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.16 actual daily | 54 54% of assets are less volatile |
Expected Return
| 0.56 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average BioLight Life is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioLight Life by adding it to a well-diversified portfolio.
BioLight Life Fundamentals Growth
BioLight Stock prices reflect investors' perceptions of the future prospects and financial health of BioLight Life, and BioLight Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioLight Stock performance.
| Return On Equity | -0.0911 | |||
| Return On Asset | -0.0925 | |||
| Current Valuation | 13.59 M | |||
| Shares Outstanding | 4.56 M | |||
| Price To Earning | 82.18 X | |||
| Price To Book | 0.61 X | |||
| Price To Sales | 4,937 X | |||
| Revenue | 3 K | |||
| EBITDA | (1.36 M) | |||
| Cash And Equivalents | 39.85 M | |||
| Cash Per Share | 8.77 X | |||
| Book Value Per Share | 13.87 X | |||
| Cash Flow From Operations | (10.03 M) | |||
| Earnings Per Share | 0.08 X | |||
| Total Asset | 64.17 M | |||
| Retained Earnings | (218 M) | |||
| Current Asset | 45 M | |||
| Current Liabilities | 6 M | |||
About BioLight Life Performance
By analyzing BioLight Life's fundamental ratios, stakeholders can gain valuable insights into BioLight Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BioLight Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BioLight Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions comprising glaucoma, dry eye syndrome, and age-related macular degeneration. BioLight Life Sciences Ltd. was founded in 2005 and is based in Tel Aviv, Israel. BIOLIGHT LIFE operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.Things to note about BioLight Life Sciences performance evaluation
Checking the ongoing alerts about BioLight Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BioLight Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioLight Life is way too risky over 90 days horizon | |
| BioLight Life appears to be risky and price may revert if volatility continues | |
| BioLight Life Sciences has accumulated about 39.85 M in cash with (10.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.77. | |
| Roughly 56.0% of the company shares are held by company insiders |
- Analyzing BioLight Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioLight Life's stock is overvalued or undervalued compared to its peers.
- Examining BioLight Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioLight Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioLight Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioLight Life's stock. These opinions can provide insight into BioLight Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for BioLight Stock analysis
When running BioLight Life's price analysis, check to measure BioLight Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLight Life is operating at the current time. Most of BioLight Life's value examination focuses on studying past and present price action to predict the probability of BioLight Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLight Life's price. Additionally, you may evaluate how the addition of BioLight Life to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |